Hai-Yu Hong, Teng-Yu Chen, Qin-Tai Yang, Yue-Qi Sun, Feng-Hong Chen, Hong-Fei Lou, Hong-Tian Wang, Rui-Li Yu, Yun-Fang An, Feng Liu, Tian-Sheng Wang, Mei-Ping Lu, Qian-Hui Qiu, Xiang-Dong Wang, Jian-Jun Chen, Cui-da Meng, Zhi-Hai Xie, Juan Meng, Ming Zeng, Cheng-Li Xu, Ying Wang, Yu-Cheng Yang, Wei-Tian Zhang, Jun Tang, Yan-Li Yang, Rui Xu, Guo-Dong Yu, Zhao-Hui Shi, Xin Wei, Hui-Ping Ye, Ya-Nan Sun, Shao-Qing Yu, Tian-Hong Zhang, Jun Yong, Wei Hang, Yuan-Teng Xu, Yu Xu, Guo-Lin Tan, Na Sun, Gui Yang, You-Jin Li, Jing Ye, Ke-Jun Zuo, Li-Qiang Zhang, Xue-Yan Wang, An-Ni Yang, Ying-Xiang Xu, Wei Liao, Yun-Ping Fan, Hua-Bin Li
BACKGROUND: Chronic rhinosinusitis (CRS) is a common inflammatory disease in otolaryngology, mainly manifested as nasal congestion, nasal discharge, facial pain/pressure, and smell disorder. CRS with nasal polyps (CRSwNP), an important phenotype of CRS, has a high recurrence rate even after receiving corticosteroids and/or functional endoscopic sinus surgery. In recent years, clinicians have focused on the application of biological agents in CRSwNP. However, it has not reached a consensus on the timing and selection of biologics for the treatment of CRS so far...
April 5, 2023: ORL; Journal for Oto-rhino-laryngology and its related Specialties